The company’s consolidated revenues (including German subsidiary, AxiCorp) jumped 83 per cent in the June quarter to Rs 505 crore from Rs 277 crores in last year. AxiCorp engaged in a distribution business, has registered a top line of Rs190 crores.
Commenting on the results, Kiran Mazumdar-Shaw, Chairman & Managing Director, Biocon Limited, said, “Biocon’s Q1 performance has delivered robust growth across all segments. This trend holds good prospects for year ahead.” Biocon is has made good progress on research with several programs approaching a licensing potential.
Published 23 July 2009, 16:25 IST